|Nome:||Bruno Filipe Carmelino Cardoso Sarmento|
Bruno Sarmento is Principal Investigator at INEB/i3S, Institute of Biomedical Engineering/Institute for Investigation and Innovation in Health, University of Porto, and Assistant Professor at IUCS, Instituto Universitário de Ciências da Saúde, Portugal.
He graduated in Pharmaceutical Sciences at the University of Porto (UP) in 2002 and completed a PhD in Pharmaceutical Nanotechnology at UP in 2007, in collaboration with Queen’s University (CA), University of Copenhagen (DK) and University of Santiago de Compostela (ES). From 2007 to 2012 he held a Post-Doc position at UP, in collaboration with the University of Copenhagen. In 2008 he was appointed Assistant Professor at IUCS. He also co-founded Inovapotek in 2008, and is member of its advisory board. In 2012 he became Associated Researcher at INEB, where established an independent team. He was appointed as Assistant Researched at INEB/i3S in 2016. He is Visiting Professor of the Post-Graduate School, UniOeste (BR) and Visiting Research Professor at Queen’s University, Belfast (UK).
So far, he has supervised/co-supervised 10 Post-Docs (7 completed), 34 PhD students (19 completed) and 33 MSc students (30 completed), and 11 researcher assistants. He attracted direct competitive funding worth more than 6 M¤, at national and international levels.
His current research is focused on the development of functionalized nanomedicines and their application in the pharmaceutical and biomedical fields. In particular, nanoformulations of biopharmaceutical drugs with interest in diabetes, cancer and infectious diseases. He has also specialized in mucosal tissue engineering models to validate functionalized nanomedicines and to perform in vitro/in vivo correlation. He published more than 280 papers in international peer reviewed (ISI) journals, most in top journals (Q1 in Pharmaceutical Sciences; Q1 in Nanoscience and Nanotechnology; total citations in Scopus 6918; H-index 43 and in GoogleScholar 9620; H-index 46), 45 book chapters and more than 200 proceedings. He edited 5 books, participated in more than 50 invited/selected talks in national and international meetings and was awarded several distinctions. He is editor of European Journal of Pharmaceutical Sciences, and member of the Editorial Advisory Board of 11 international journals, including the prestigious Journal of Controlled Release and Expert Opinion on Drug Delivery. Bruno Sarmento is the Chair of the Chair of the Nanomedicine and Nanoscale Drug Delivery Focus Group of the Controlled Release Society. He has acted as referee for top-ranked journals in his area of expertise, and for international funding agencies: FNRS (BE), Inserm (FR), CNCS (RO), FCT (PT), Foncyt (ARG), CNPq (BR) and European Commission. In addition to being a partner in several research projects, he was the PI of competitively funded projects (FCT, Gilead and CESPU), PI of different bilateral collaborative projects between Portugal (FCT) and foreinger funding agencies as well as partner of several European projects funded by European Comission.